三七通舒胶囊治疗60例急性面神经炎患者的临床研究  

Sanqitongshu Capsule for 60 Patients with Acute Facial Neuritis Patients:A Clinical Trial

作　　者：张震中[1] 张燕[1] 祁建国[1] 

机构地区：[1]新疆医科大学附属中医医院,乌鲁木齐830000

出　　处：《中国循证医学杂志》2009年第12期1346-1347,共2页Chinese Journal of Evidence-based Medicine

摘　　要：目的比较三七通舒胶囊加西药基础治疗与单用西药治疗面神经炎的疗效差异。方法将60例面神经炎患者按门诊顺序分为治疗组和对照组各30例,对照组采用口服强的松20mg+非特异性抗炎治疗,隔日1次,1周后停药;配合口服维生素B1、维生素B12改善神经代谢,30天为1疗程。而治疗组则在前述治疗基础上加用三七通舒胶囊(每粒含三七三醇皂苷100mg)。结果治疗组治疗4周后,20例痊愈,5例显效,2例有效,总有效率达90%;而对照组10例痊愈,3例显效,2例有效,总有效率仅为50.0%;两组间总有效率差异有统计学意义(P<0.05)。结论三七通舒胶囊加激素治疗面神经炎的疗效较好,优于单用激素治疗。Objective To compare the clinical therapeutic effects of combination therapy of Sanqitongshu capsule and prednisolone with prednisolone alone in the treatment of acute peripheral facial neuritis. Methods A total of 60 patients with facial paralysis were divided into the treatment group and the control group in the outpatient order. The control group used 20 mg oral prednisolone and accepted the non-specific anti-inflammatory treatment every other day. Medication would stop in a week. Oral administration of vitamin B1 and vitamin B12 was also performed for nerve metabolism improvement for 30 days. The therapy of the treatment group was based on the same treatment of the control group with Sanqitongshu capsule for 30 days. Results After 4 weeks, in the treatment group, 20 patients recovered, 5 markedly effective, and 2 effective, and the total effective rate was 90%. In the Control group, 10 patients recovered, 3 markedly effective, and 2 effective, and the total effective rate was 50.0%. There were significant differences between the two groups （P〈0.05）. Conclusion The clinical effectiveness of Sanqitongshu capsule plus prednisolone is better than that of prednisolone alone in the treatment of acute peripheral facial neuritis.

关 键 词：急性面神经炎 三七通舒胶囊 强的松 神经电生理指标 

分 类 号：R277.7[医药卫生—中医学]